-
Added DIVISLAB to watchlistThe company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports.Unattractive Valuation Sales Growth > 10% Profit Margin > 15% NIFTY 50 + 20 indices